Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Ewing 1Sarcoma 1Osteosarcoma 1Osteitis Deformans 1Bone Neoplasms 1

Interventions

Methotrexate 3Ifosfamide 3Cisplatin 3Magnetic Resonance Spectroscopy 2Leucovorin 2Electroacupuncture 2Doxorubicin 2sargramostim 1regorafenib 1delta 24-sterol reductase 1apatinib 1Tissue and Organ Procurement 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Resistance Training 1Radiotherapy, Image-Guided 1Proton Therapy 1Positron Emission Tomography Computed Tomography 1Physical Therapy Modalities 1Pentetic Acid 1Palliative Care 1Nutritional Support 1Neuropsychological Tests 1Neoadjuvant Therapy 1Minocycline 1Mesna 1Heparin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Glutamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Osteosarcoma × delta 24-sterol reductase × Clear all
NCT01882231 2017-05-08

Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
6 enrolled
Sarcoma

Bone Neoplasms, Osteitis Deformans, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡